Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate - CNBC

Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate  CNBC

Pharmaceutical giant Pfizer braced investors for little-to-no revenue growth in 2019 after its blockbuster erectile dysfunction drug Viagra and others lost patent ...